Proteomic analysis of protein expression and oxidative modification in R6/2 transgenic mice

被引:145
|
作者
Perluigi, M
Poon, HF
Maragos, W
Pierce, WM
Klein, JB
Calabrese, V
Cini, C
De Marco, C
Butterfield, DA [1 ]
机构
[1] Univ Kentucky, Ctr Membrane Sci, Dept Chem, Lexington, KY 40506 USA
[2] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy
[3] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA
[4] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA
[5] Univ Louisville, Sch Med, Kidney Dis Program, Louisville, KY 40292 USA
[6] Univ Louisville, Sch Med, Core Proteom Lab, Louisville, KY 40292 USA
[7] Univ Louisville, Sch Med, Dept Pharmacol, Louisville, KY 40292 USA
[8] Vet Affairs Med Ctr, Louisville, KY 40292 USA
[9] Univ Catania, Dept Chem, Biochem Sect, I-95100 Catania, Italy
[10] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40506 USA
关键词
D O I
10.1074/mcp.M500090-MCP200
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Huntington disease (HD) is a hereditary neurodegenerative disorder characterized by motor, psychiatric, and cognitive symptoms. The genetic defect responsible for the onset of the disease, expansion of CAG repeats in exon 1 of the gene that codes for huntingtin on chromosome 4, has been unambiguously identified. On the other hand, the mechanisms by which the mutation causes the disease are not completely understood yet. However, defects in energy metabolism of affected cells may cause oxidative damage, which has been proposed as one of the underlying molecular mechanisms that participate in the etiology of the disease. In our effort to investigate the extent of oxidative damage occurring at the protein level, we used a parallel proteomic approach to identify proteins potentially involved in processes upstream or downstream of the disease-causing huntingtin in a well established HD mouse model (R6/2 transgenic mice). We have demonstrated that the expression levels of dihydrolipoamide S-succinyltransferase and aspartate aminotransferase increase consistently over the course of disease (10-week-old mice). In contrast, pyruvate dehydrogenase expression levels were found to be decreased in 10-week-old HD transgenic mice compared with young (4-week-old) mice. Our experimental approach also led to the identification of oxidatively modified proteins. Six proteins were found to be significantly oxidized in old R6/2 transgenic mice compared with either young transgenic mice or non-transgenic mice. These proteins are alpha-enolase, gamma-enolase (neuron-specific enolase), aconitase, the voltage-dependent anion channel 1, heat shock protein 90, and creatine kinase. Because oxidative damage has proved to play an important role in the pathogenesis and the progression of Huntington disease, our results for the first time identify specific oxidatively modified proteins that potentially contribute to the pathogenesis of Huntington disease.
引用
收藏
页码:1849 / 1861
页数:13
相关论文
共 50 条
  • [31] Euploidy in somatic cells from R6/2 transgenic Huntington's disease mice -: art. no. 34
    Petersén, Å
    Stewénius, Y
    Björkqvist, M
    Gisselsson, D
    BMC CELL BIOLOGY, 2005, 6 (1)
  • [32] Motor phenotype is not associated with vascular dysfunction in symptomatic Huntington’s disease transgenic R6/2 (160 CAG) mice
    A. Di Pardo
    A. Carrizzo
    A. Damato
    S. Castaldo
    E. Amico
    L. Capocci
    M. Ambrosio
    F. Pompeo
    C. De Sanctis
    C. C. Spinelli
    A. A. Puca
    P. Remondelli
    V. Maglione
    C. Vecchione
    Scientific Reports, 7
  • [33] MITOCHONDRIAL PROTEOME ANALYSIS OF R6/2 MOUSE BRAINS
    Fleischer, C.
    Lehnert, S.
    Jahn, O.
    Otto, M.
    Landwehrmeyer, G. B.
    Lindenberg, K. S.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 : A4 - A4
  • [34] Altered Dopamine and Serotonin Metabolism in Motorically Asymptomatic R6/2 Mice
    Mochel, Fanny
    Durant, Brandon
    Durr, Alexandra
    Schiffmann, Raphael
    PLOS ONE, 2011, 6 (03):
  • [35] Asialoerythropoetin is not effective in the R6/2 line of Huntington's disease mice
    Gil J.
    Leist M.
    Popovic N.
    Brundin P.
    Petersén Å.
    BMC Neuroscience, 5 (1)
  • [36] Morphological and functional evaluation of retinal ganglion cells in R6/2 mice
    Ragauskas, Symantas
    Leinonen, Henri Olavi
    Puranen, Jooseppi
    Nymark, Soile
    Lipponen, Arto
    Gurevicius, Kestutis
    Kontkanen, Outi
    Puolivali, Jukka
    Tanila, Heikki
    Kalesnykas, Giedrius
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [37] Longitudinal analysis of the behavioural phenotype in R6/1 (C57BL/6J) Huntington's disease transgenic mice
    Brooks, Simon P.
    Janghra, Nari
    Workman, Victoria L.
    Bayram-Weston, Zubeyde
    Jones, Lesley
    Dunnett, Stephen B.
    BRAIN RESEARCH BULLETIN, 2012, 88 (2-3) : 94 - 103
  • [38] Gene expression profiling of R6/2 transgenic mice with different CAG repeat lengths reveals genes associated with disease onset and progression in Huntington's disease
    Tang, Bin
    Seredenina, Tamara
    Coppola, Giovanni
    Kuhn, Alexandre
    Geschwind, Daniel H.
    Luthi-Carter, Ruth
    Thomas, Elizabeth A.
    NEUROBIOLOGY OF DISEASE, 2011, 42 (03) : 459 - 467
  • [39] Repeated immune activation with low-dose lipopolysaccharide attenuates the severity of Huntington's disease in R6/2 transgenic mice
    Lee, Sung Won
    Park, Hyun Jung
    Im, Wooseok
    Kim, Manho
    Hong, Seokmann
    ANIMAL CELLS AND SYSTEMS, 2018, 22 (04) : 219 - 226
  • [40] Evaluation of R6/2 HD transgenic mice for therapeutic studies in Huntington's disease:: behavioral testing and impact of diabetes mellitus
    Lüesse, HG
    Schiefer, J
    Spruenken, A
    Puls, C
    Block, F
    Kosinski, CM
    BEHAVIOURAL BRAIN RESEARCH, 2001, 126 (1-2) : 185 - 195